595 Burrard Street
Vancouver, BC V7X 1L4
Canada
604-641-4466
https://www.sironabiochem.com
Settore/i: Healthcare
Settore: Biotechnology
Impiegati a tempo pieno:
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Dr. Howard J. Verrico M.D., Ph.D. | Founder, Chairman of the Board, CEO & Secretary | 180,64k | N/D | 1961 |
Mr. Christopher D. Hopton C.G.A., CPA | CFO & Director | 147,84k | N/D | 1966 |
Dr. Géraldine Deliencourt-Godefroy Ph.D. | Chief Scientific Officer & Director | 213,39k | N/D | N/D |
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.
L'ISS Governance QualityScore di Sirona Biochem Corp. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.